title: Rhabdomyolysis due to Lamivudine administration in a liver transplant recipient.
authors.forename: Gian Luigi
authors.initials: GL
authors.lastname: Adani
authors.forename: Umberto
authors.initials: U
authors.lastname: Baccarani
authors.forename: Andrea
authors.initials: A
authors.lastname: Risaliti
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Bresadola
authors.forename: Giorgio
authors.initials: G
authors.lastname: Della Rocca
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Viale
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D006509:Hepatitis B / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine